PubRank

Yuichi Tanabe

Author PubWeight™ 21.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study. J Hepatol 2012 2.91
2 Long-term fibrate treatment for PBC. J Gastroenterol 2005 1.48
3 A rare case of idiopathic hypereosinophilic syndrome involving the oral cavity associated with the esophagus and gastrointestinal tract. Intern Med 2004 1.38
4 Mitochondrial DNA data indicate an introduction through Mainland Southeast Asia for Australian dingoes and Polynesian domestic dogs. Proc Biol Sci 2011 1.21
5 Allele frequency distribution of the canine dopamine receptor D4 gene exon III and I in 23 breeds. J Vet Med Sci 2004 1.04
6 Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy. J Hepatol 2013 1.03
7 Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C. J Hepatol 2013 1.00
8 Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol 2009 0.97
9 Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group. J Gastroenterol Hepatol 2008 0.92
10 Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C. World J Gastroenterol 2010 0.89
11 Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group. World J Gastroenterol 2006 0.85
12 Body surface area is an independent factor contributing to the effects of lamivudine treatment. Hepatol Res 2004 0.83
13 Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism. J Gastroenterol 2005 0.83
14 Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study. World J Gastroenterol 2006 0.81
15 Apolipoprotein E and H polymorphisms in Mongolian Buryat: allele frequencies and relationship with plasma lipid levels. Hum Biol 2002 0.80
16 Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study. J Gastroenterol Hepatol 2012 0.80
17 Polymorphism of the apolipoprotein B gene and association with plasma lipid and lipoprotein levels in the Mongolian Buryat. Biochem Genet 2011 0.80
18 Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients. Comp Hepatol 2007 0.78
19 Pegylated interferon α-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase. Hepatol Res 2011 0.77
20 An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. J Infect Chemother 2012 0.76
21 Relationship between body surface area and ALT normalization after long-term lamivudine treatment. World J Gastroenterol 2005 0.76
22 Unconventional colossal magnetoresistance in sodium chromium oxide with a mixed-valence state. Angew Chem Int Ed Engl 2012 0.75
23 Beta-globin gene cluster haplotype frequencies in Khalkhs and Buryats of Mongolia. Hum Biol 2006 0.75
24 Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infection. Intern Med 2015 0.75
25 Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis. J Gastroenterol Hepatol 2014 0.75